Compare
MRNA vs ABBV vs AMGN vs GILD
Up to five stocks or ETFs side by side. Performance is rebased to 100 at the start of the window.
Relative performance
| MRNA | ABBV | AMGN | GILD | |
|---|---|---|---|---|
| Price | $254.19 | $291.31 | $460.42 | $166.89 |
| 1-day | +5.27% | +1.07% | +0.03% | -0.41% |
| YTD | +761.95% | +27.49% | +40.67% | +35.97% |
| 1 year | +978.90% | +34.39% | +43.94% | +36.15% |
| 3 years | +233.58% | +104.47% | +76.51% | +108.12% |
| Market cap | $102.8B | $514.9B | $249.1B | $207.0B |
| P/E | — | 50.1 | 26.7 | — |
| P/S | 40.73 | 7.80 | 6.40 | 6.68 |
| P/B | 15.04 | — | 17.35 | 15.87 |
| Revenue growth | +13.10% | +10.70% | +8.20% | +6.50% |
| EPS growth | — | +340.20% | +33.30% | -149.00% |
| Gross margin % | 28.0 | 73.7 | 70.9 | 79.9 |
| Net margin % | -110.5 | 15.7 | 24.1 | -12.5 |
| ROE % | -40.8 | — | 65.4 | -29.6 |
| Debt / equity | 0.09 | — | 3.76 | 2.01 |
| FCF yield % | -1.9 | 3.7 | 3.8 | 6.7 |
| Dividend yield % | — | 2.38 | 2.16 | 1.95 |
| Beta | 2.27 | -0.03 | 0.50 | 0.37 |
| RSI (14) | 63.7 | 59.7 | 60.5 | 60.2 |
| Technical rating |